Trial drug could reduce side-effects of blood cancer treatments
TOPICAL, a clinical trial led by The Christie NHS Foundation Trust, is set to test a new drug that could make cutting-edge cancer treatments safer and more accessible for thousands of patients with multiple myeloma, a type of blood cancer.
Read Trial drug could reduce side-effects of blood cancer treatments Article